When you participate in the Walk 4 CMT campaign, you fund patient programs and treatment research initiatives to better the lives of the the 3 million people living with CMT.
By investing in the CMTA’s Legacy Society, you can ensure that children with CMT will grow up with the hope of a world without CMT.
Acceleron recruited adults with CMT1 and CMTX for a Phase 2 clinical trial studying investigational drug ACE-083.
Thank you for your interest in participating, but the study is fully subscribed and registration is closed.
